| KREBSBIO | | | 104.14 8.79 7.78% |
Krebs Biochemicals financial indicator trend analysis is infinitely more than just investigating Krebs Biochemicals and recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Krebs Biochemicals and is a good investment. Please check the relationship between Krebs Biochemicals Operating Income and its Total Operating Expenses accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Krebs Biochemicals and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in state.
Operating Income vs Total Operating Expenses
Operating Income vs Total Operating Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Krebs Biochemicals and Operating Income account and
Total Operating Expenses. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Krebs Biochemicals' Operating Income and Total Operating Expenses is -0.41. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Total Operating Expenses in the same time period over historical financial statements of Krebs Biochemicals and, assuming nothing else is changed. The correlation between historical values of Krebs Biochemicals' Operating Income and Total Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Krebs Biochemicals and are associated (or correlated) with its Total Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Operating Expenses has no effect on the direction of Operating Income i.e., Krebs Biochemicals' Operating Income and Total Operating Expenses go up and down completely randomly.
Correlation Coefficient | -0.41 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Operating Income
Operating Income is the amount of profit realized from Krebs Biochemicals and operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Krebs Biochemicals and is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.
Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most indicators from Krebs Biochemicals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Krebs Biochemicals and current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Krebs Biochemicals and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in state.
The current
Selling General Administrative is estimated to decrease to about 5.7
M. The current
Issuance Of Capital Stock is estimated to decrease to about 61.2
M | 2021 | 2022 | 2023 | 2024 (projected) |
Total Operating Expenses | 195.1M | 488.0M | 46.2M | 43.8M | Cost Of Revenue | 737M | 256.8M | 613.0M | 342.2M |
Krebs Biochemicals fundamental ratios Correlations
Click cells to compare fundamentals
Krebs Biochemicals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Krebs Biochemicals fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Krebs Stock
Balance Sheet is a snapshot of the
financial position of Krebs Biochemicals and at a specified time, usually calculated after every quarter, six months, or one year. Krebs Biochemicals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Krebs Biochemicals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Krebs currently owns. An asset can also be divided into two categories, current and non-current.